Pricing Log in Create free account

Molecular Partners AG Sponsored ADR (MOLN) vs NovaBridge Biosciences (NBP)

Molecular Partners AG Sponsored ADR and NovaBridge Biosciences are both Biotechnology companies. Molecular Partners AG Sponsored ADR and NovaBridge Biosciences are of similar size ($149.6M and $143.5M). Molecular Partners AG Sponsored ADR grew revenue faster over the last twelve months: −28.0% against −91.8%. Across the 13 metrics below, NovaBridge Biosciences leads on 8 and Molecular Partners AG Sponsored ADR on 5.

Valuation

Metric MOLN NBP Biotechnology median
P/E n/m n/m 8.50
P/S 24.43 5.31 9.71
P/B 1.86 0.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.94 0.64
EV/Sales 9.21 (3.81) 9.21
Earnings yield (48.03%) (38.61%) (33.15%)
Free cash flow yield (41.59%) (89.83%) (25.50%)

Profitability

Metric MOLN NBP Biotechnology median
Gross margin 0.00% 31.10% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (63.89%) 0.00% (56.36%)
Return on assets (52.73%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MOLN NBP Biotechnology median
Revenue growth (TTM) (27.99%) (91.84%) 6.02%
EPS growth (last fiscal year) (9.94%) (77.78%) 30.26%
Revenue growth, 5-year CAGR (23.12%) (40.00%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MOLN NBP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.27 7.64 4.72
Net debt to EBITDA 1.66 2.26 0.96

Dividend

Metric MOLN NBP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MOLN NBP Biotechnology median
Market cap 143.47m 149.64m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack